Forest Laboratories, Inc.(theInvestmentSection)

Research, September, 2005

Profile: Forest Laboratories, Inc. (NYSE: FRX) develops, manufactures, and markets prescription pharmaceutical products in the U.S. Forest has successful branded pharmaceutical products; and strong revenue and profit growth.

Forest's key products, marketed in the U.S., are branded pharmaceuticals:

* Lexapro[R] is a selective serotonin reuptake inhibitor (SSRI) for treating depression and generalized anxiety disorder in adults. It is the fastest growing product in this market.

* Namenda[R] is an NMDA receptor antagonist and the only approved product for the treatment of moderate to severe Alzheimer's Disease.

* Benicar[R] and Benicar HCT[R]* are angiotensin receptor blockers for the treatment of hypertension. These products are...

Read the rest of this article with a Free Trial at HighBeam Research.

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works.